{"article_link": "https://www.frontiersin.org/articles/10.3389/fimmu.2022.938240/full", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://www.ncbi.nlm.nih.gov/bioproject/PRJNA859010", "format": "FASTQ", "source": "Sequence Read Archive (SRA)", "public_id": "PRJNA859010", "description": "Bulk RNA-seq data from unstimulated and CD40L/IL21-stimulated naÃ¯ve B cells", "technology": "Illumina NextSeq 6000", "experimental_group": ["affected TACI mutation carriers", "unaffected TACI mutation carriers", "wild-type"]}, {"id": "data_2", "omics": "Genomics", "link": "https://www.ncbi.nlm.nih.gov/bioproject/PRJNA859010", "format": "FASTQ", "source": "Sequence Read Archive (SRA)", "public_id": "PRJNA859010", "description": "ATAC-seq data from unstimulated and CD40L/IL21-stimulated naÃ¯ve B cells", "technology": "Illumina HiSeq 2500/4000", "experimental_group": ["affected TACI mutation carriers", "unaffected TACI mutation carriers", "wild-type"]}, {"id": "data_3", "omics": "Proteomics", "link": "http://www.proteomexchange.org/cgi/GetDataset?ID=PXD035459", "format": "Mass Spectrometry Raw Files", "source": "ProteomeXchange", "public_id": "PXD035459", "description": "LC-MS/MS proteomics data from CD40L/IL21-stimulated naÃ¯ve B cells", "technology": "Q Exactive HF Orbitrap", "experimental_group": ["affected TACI mutation carriers", "unaffected TACI mutation carriers", "wild-type"]}], "analyses": [{"id": "analysis_1", "analysis_type": "ATAC-seq", "analysis_data": ["data_2"], "label": {"condition": ["unstimulated", "stimulated"]}, "description": "Chromatin accessibility profiling using Bowtie/Bowtie2 for alignment and HOMER for peak calling"}, {"id": "analysis_2", "analysis_type": "Bulk RNA-seq", "analysis_data": ["data_1"], "label": {"condition": ["unstimulated", "stimulated"]}, "description": "Transcriptome profiling using FastQC, Trimmomatic, STAR for alignment, and DESeq2 for differential expression"}, {"id": "analysis_3", "analysis_type": "Proteomics", "analysis_data": ["data_3"], "label": {"condition": ["stimulated"]}, "description": "Proteome profiling using MaxQuant with Andromeda search engine, label-free quantification (LFQ), and limma for differential analysis"}, {"id": "analysis_4", "analysis_type": "Differential analysis (ATAC-seq)", "analysis_data": ["analysis_1"], "label": {"group": ["affected TACI mutation carriers", "unaffected TACI mutation carriers", "wild-type"]}, "description": "Differential accessible chromatin regions analysis using HOMER and edgeR"}, {"id": "analysis_5", "analysis_type": "Differential analysis (RNA-seq)", "analysis_data": ["analysis_2"], "label": {"group": ["affected TACI mutation carriers", "wild-type"]}, "description": "Differential gene expression analysis using DESeq2 (log2FC >0.5, adjusted p <0.05)"}, {"id": "analysis_6", "analysis_type": "Differential analysis (Proteomics)", "analysis_data": ["analysis_3"], "label": {"group": ["affected TACI mutation carriers", "wild-type"]}, "description": "Differential protein expression analysis using limma (log2FC >0.5, p <0.05)"}, {"id": "analysis_7", "analysis_type": "Gene set enrichment analysis (RNA-seq)", "analysis_data": ["analysis_2"], "label": {"condition": ["unstimulated", "stimulated"]}, "description": "Pathway enrichment analysis using fgsea with Hallmark gene sets"}, {"id": "analysis_8", "analysis_type": "Gene set enrichment analysis (Proteomics)", "analysis_data": ["analysis_3"], "label": {"condition": ["stimulated"]}, "description": "Pathway enrichment analysis using Hallmark gene sets based on proteomics data"}, {"id": "analysis_9", "analysis_type": "Differential analysis (RNA-seq: unstimulated vs. stimulated)", "analysis_data": ["analysis_2"], "label": {"condition": ["unstimulated", "stimulated"]}, "description": "Comparison of RNA-seq results between unstimulated and CD40L/IL21-stimulated conditions"}, {"id": "analysis_10", "analysis_type": "Differential analysis (Proteomics: unstimulated vs. stimulated)", "analysis_data": ["analysis_3"], "label": {"condition": ["unstimulated", "stimulated"]}, "description": "Comparison of proteomics results between unstimulated and CD40L/IL21-stimulated conditions"}], "results": [{"analysis_id": "analysis_4", "metric": "Number of differentially accessible regions (DARs)", "value": "1,356 (743 up, 613 down)", "features": ["NF-kB", "ETS", "IRF", "POU", "E2F"]}, {"analysis_id": "analysis_5", "metric": "Number of differentially expressed genes (DEGs) with log2FC >0.5 and adjusted p <0.05", "value": "13 (5 up, 8 down)", "features": ["HLA-B", "NR4A2", "THEMIS2", "QPCT", "GADD45B", "CCNB3", "AXIN2", "ZNF235", "DNAJC12", "UBXN10", "MANSC1", "TRIP13", "JPT2", "TNF-a signaling pathway via NF-kB", "p53 signaling pathway", "fatty acid metabolism pathway", "interferon-a response pathway"]}, {"analysis_id": "analysis_6", "metric": "Number of differentially expressed proteins with log2FC >0.5 and p <0.05", "value": "3,805 (1,768 up, 2,037 down)", "features": ["coagulation pathway", "interferon-a (IFN-a) pathway", "interferon-g (IFN-g) pathway", "MYC-V2 target genes", "E2F targets"]}, {"analysis_id": "analysis_7", "metric": "Enriched pathways", "value": "TNF-a signaling pathway via NF-kB, hypoxia, p53 signaling pathway, UV response, interferon-a response pathway, fatty acid metabolism pathway, protein secretion, oxidative phosphorylation, complement, inflammatory response, allograft rejection, MYC-V2 target genes", "features": ["TNF-a signaling pathway via NF-kB", "p53 signaling pathway", "interferon-a response pathway", "fatty acid metabolism pathway", "oxidative phosphorylation"]}, {"analysis_id": "analysis_8", "metric": "Enriched pathways", "value": "coagulation pathway, interferon-a (IFN-a) pathway, interferon-g (IFN-g) pathway, oxidative phosphorylation, MYC-V2 target genes, E2F targets, DNA repair pathways", "features": ["coagulation pathway", "interferon-a (IFN-a) pathway", "interferon-g (IFN-g) pathway", "MYC-V2 target genes", "E2F targets"]}, {"analysis_id": "analysis_9", "metric": "Unstimulated vs. stimulated RNA-seq differences", "value": "1,558 DEGs (720 up, 838 down)", "features": ["complement pathway", "inflammatory response pathway", "allograft rejection pathway", "MYC-V2 target genes"]}, {"analysis_id": "analysis_10", "metric": "Unstimulated vs. stimulated proteomics differences", "value": "3,805 DPEPs (1,768 up, 2,037 down)", "features": ["oxidative phosphorylation pathway", "E2F targets", "DNA repair pathways"]}]}